Background: To investigate the effect of (103)Pd radioactive stent on Caspase-9, cholangiocarcinoma cell growth and its radiosensitivity.
Methods: Cholangiocarcinoma was treated with (103)Pd radioactive stent at different period. Radiosensitivity of the cells was detected by methyl thiazolyl tetrazolium (MTT) method. Apoptosis of cholangiocarcinoma cells was detected by immunohistochemistry and electron microscope. The activity of Caspase-9 was detected by non-radioimmunoprecipitation, while its protein expression was detected by Western blot.
Results: (103)Pd radioactive stent had significant inhibitive effect on cholangiocarcinoma cells and it could induce apoptosis. After treatment by (103)Pd radioactive stent for 10 days, the activity of Caspase-9 was gradually enhanced, which was markedly decreased in common stent group. Cholangiocarcinoma cells had relatively high sensitivity to (103)Pd radiation.
Conclusion: (103)Pd radioactive stent can activate caspase-9 gene to induce apoptosis of cholangiocarcinoma cell, inhibit its growth and enhance its radiosensitivity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.suronc.2010.02.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Nanoscale dosimetry for a radioisotope-labeled metal nanoparticle using MCNP6.2 and Geant4.
Med Phys
December 2024
Department of Applied Bioengineering and Research Institute for Convergence Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea.
Background: Metal nanoparticles (MNPs) labeled with radioisotopes (RIs) are utilized as radio-enhancers due to their ability to amplify the radiation dose in their immediate vicinity. A thorough understanding of nanoscale dosimetry around MNPs enables their effective application in radiotherapy. However, nanoscale dosimetry around MNPs still requires further investigation.
View Article and Find Full Text PDFTumor Shape-Specific Brachytherapy Implants by 3D-Printing, Precision Radioactivity Painting, and Biomedical Imaging.
Adv Healthc Mater
October 2023
Département de Génie des Mines, de la Métallurgie et des Matériaux and Centre de recherche sur les matériaux avancés (CERMA), Université Laval, Québec, G1V 0A6, Canada.
In brachytherapy (BT), or internal radiation therapy, cancer is treated by radioactive implants. For instance, episcleral plaques (EPs) for the treatment of uveal melanoma, are designed according to generic population approximations. However, more personalized implants can enhance treatment precision through better adjustment of dose profiles to the contours of cancerous tissues.
View Article and Find Full Text PDFComparison between dose distribution from Pd, Cs, and I plaques in a real human eye model with different tumor size.
Appl Radiat Isot
April 2022
Department of Physics, Faculty of Science, University of Guilan, Rasht, Iran.
Knowledge of the energy deposition in different eye components is a critical decision-making to the overall effectivity of ocular melanoma treatment with plaques loaded with low-energy sources. The aim of this study is using the GATE 8.2 Monte Carlo code to calculate the 3D dose distribution in a realistic eye model.
View Article and Find Full Text PDFMonte Carlo simulations for dose enhancement in cancer treatment using bismuth oxide nanoparticles implanted in brain soft tissue.
Australas Phys Eng Sci Med
June 2018
Nuclear Engineering Department, Faculty of Engineering, King Abdulaziz University, P. O. Box 80204, Jeddah, 21589, Saudi Arabia.
The objective of this work is to study the dosimetric performances of bismuth oxide nanoparticles implanted in tumors in cancer radiotherapy. GEANT4 based Monte Carlo numerical simulations were performed to assess dose enhancement distributions in and around a 1 × 1 × 1 cm tumor implanted with different concentrations of bismuth oxide and irradiated with low energies I, Cs, and Pd radioactive sources. Dose contributions were considered from photoelectrons, Auger electrons, and characteristic X-rays.
View Article and Find Full Text PDFBilateral simultaneous primary choroidal melanomas: Treated with palladium-103 plaque radiation.
Eur J Ophthalmol
September 2018
The New York Eye Cancer Center, New York, NY, USA.
Purpose: To provide a clinical description of a case of bilateral choroidal melanoma in a patient treated with palladium-103 (Pd) plaque brachytherapy.
Methods: An 81-year-old man presented with choroidal melanoma in both eyes. In consideration of tumor sizes and locations, treatment involved insertion of Pd radioactive plaque in the right eye followed by the left at an interval of 2 months.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!